{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T09:25:37Z","timestamp":1794043537675,"version":"4.8.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jem-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Emergency Medicine"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.jemermed.2025.09.031","type":"journal-article","created":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T04:07:47Z","timestamp":1758946067000},"page":"545-550","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Remimazolam: A Novel Frontier in Procedural Sedation for Emergency Medicine"],"prefix":"10.1016","volume":"79","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7655-5692","authenticated-orcid":false,"given":"Jace C.","family":"Bradshaw","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laeben","family":"Lester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew R.","family":"Greer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Leon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jemermed.2025.09.031_bib0001","doi-asserted-by":"crossref","first-page":"1","DOI":"10.17085\/apm.21115","article-title":"Remimazolam: pharmacological characteristics and clinical applications in anesthesiology","volume":"17","author":"Kim","year":"2022","journal-title":"Anesth Pain Med (Seoul)"},{"key":"10.1016\/j.jemermed.2025.09.031_bib0002","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.690875","article-title":"Remimazolam: Non-clinical and clinical profile of a new sedative\/anesthetic agent","volume":"12","author":"Kilpatrick","year":"2021","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jemermed.2025.09.031_bib0003","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1097\/01.anes.0000267503.85085.c0","article-title":"CNS 7056: a novel ultra-short-acting benzodiazepine","volume":"107","author":"Kilpatrick","year":"2007","journal-title":"Anesthesiology"},{"key":"10.1016\/j.jemermed.2025.09.031_bib0004","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1177\/08971900211027303","article-title":"Remimazolam: a novel option for procedural sedation in high risk patients","volume":"36","author":"Pantos","year":"2021","journal-title":"J Pharm Pract"},{"key":"10.1016\/j.jemermed.2025.09.031_bib0005","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/j.bja.2024.02.005","article-title":"Remimazolam versus propofol for sedation in gastrointestinal endoscopic procedures: a systematic review and meta-analysis","volume":"132","author":"Barbosa","year":"2024","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.jemermed.2025.09.031_bib0006","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3892\/br.2024.1891","article-title":"Efficacy and safety of remimazolam vs. propofol for general anesthesia with tracheal intubation: systematic review and meta-analysis","volume":"22","author":"Luo","year":"2025","journal-title":"Biomed Rep"},{"key":"10.1016\/j.jemermed.2025.09.031_bib0007","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0165-6147(97)90675-1","article-title":"The benzodiazepine binding site of GABAA receptors","volume":"18","author":"Sigel","year":"1997","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.jemermed.2025.09.031_bib0008","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1372139","article-title":"Effective dose of intranasal remimazolam for preoperative sedation in preschool children: a dose-finding study using Dixon\u2019s up-and-down method","volume":"15","author":"Ni","year":"2024","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jemermed.2025.09.031_bib0009","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1213\/ANE.0b013e31823f0c28","article-title":"A placebo- and midazolam-controlled phase I single ascending-dose study evaluating the safety, pharmacokinetics, and pharmacodynamics of remimazolam (CNS 7056): Part I. Safety, efficacy, and basic pharmacokinetics","volume":"115","author":"Antonik","year":"2012","journal-title":"Anesth Analg"},{"key":"10.1016\/j.jemermed.2025.09.031_bib0010","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1097\/ALN.0000000000003103","article-title":"Pharmacokinetics and pharmacodynamics of remimazolam (CNS 7056) after continuous infusion in healthy male volunteers: Part I. Pharmacokinetics and clinical pharmacodynamics","volume":"132","author":"Sch\u00fcttler","year":"2020","journal-title":"Anesthesiology"},{"key":"10.1016\/j.jemermed.2025.09.031_bib0011","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s00540-020-02755-1","article-title":"Remimazolam besilate, a benzodiazepine, has been approved for general anesthesia!!","volume":"34","author":"Masui","year":"2020","journal-title":"J Anesth"},{"key":"10.1016\/j.jemermed.2025.09.031_bib0012","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1002\/phar.1806","article-title":"Remimazolam: pharmacologic considerations and clinical role in anesthesiology","volume":"36","author":"Wesolowski","year":"2016","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.jemermed.2025.09.031_bib0013","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s00540-020-02788-6","article-title":"Efficacy and safety of remimazolam versus propofol for general anesthesia: a multicenter, single-blind, randomized, parallel-group, phase IIb\/III trial","volume":"34","author":"Doi","year":"2020","journal-title":"J Anesth"},{"key":"10.1016\/j.jemermed.2025.09.031_bib0014","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.bja.2021.05.027","article-title":"Pharmacokinetic properties of remimazolam in subjects with hepatic or renal impairment","volume":"127","author":"St\u00f6hr","year":"2021","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.jemermed.2025.09.031_bib0015","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jpba.2017.01.016","article-title":"Metabolite characterization of a novel sedative drug, remimazolam in human plasma and urine using ultra high-performance liquid chromatography coupled with synapt high-definition mass spectrometry","volume":"137","author":"Zhou","year":"2017","journal-title":"J Pharm Biomed Anal"},{"key":"10.1016\/j.jemermed.2025.09.031_bib0016","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.coph.2005.10.003","article-title":"GABA-based therapeutic approaches: GABAA receptor subtype functions","volume":"6","author":"Rudolph","year":"2006","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.jemermed.2025.09.031_bib0017","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1042\/bst0320553","article-title":"Differentiating the role of \u03b3-aminobutyric acid type A (GABAA) receptor subtypes","volume":"32","author":"Wafford","year":"2004","journal-title":"Biochem Soc Trans"},{"key":"10.1016\/j.jemermed.2025.09.031_bib0018","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.clinthera.2023.11.004","article-title":"Remimazolam: a retrospective study of initial safety and recovery data in diverse procedural sedation","volume":"46","author":"Johnson","year":"2024","journal-title":"Clin Ther"},{"key":"10.1016\/j.jemermed.2025.09.031_bib0019","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.gie.2018.04.2351","article-title":"A phase III study evaluating the efficacy and safety of remimazolam (CNS 7056) compared with placebo and midazolam in patients undergoing colonoscopy","volume":"88","author":"Rex","year":"2018","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.jemermed.2025.09.031_bib0020","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.dld.2020.10.039","article-title":"Safety and efficacy of remimazolam in high risk colonoscopy: a randomized trial","volume":"53","author":"Rex","year":"2021","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.jemermed.2025.09.031_bib0021","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1136\/emermed-2023-213805","article-title":"Remimazolam for procedural sedation: a future sedative potential in the emergency department?","volume":"41","author":"van der Have","year":"2024","journal-title":"Emerg Med J"},{"key":"10.1016\/j.jemermed.2025.09.031_bib0022","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1111\/bcp.14270","article-title":"Potential strategy for assessing QT\/QTc interval for drugs that produce rapid changes in heart rate: electrocardiographic assessment of the effects of intravenous remimazolam on cardiac repolarization","volume":"86","author":"Kleiman","year":"2020","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jemermed.2025.09.031_bib0023","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1186\/s12871-021-01373-y","article-title":"Efficacy and safety of remimazolam besylate versus propofol during hysteroscopy: single-centre randomized controlled trial","volume":"21","author":"Zhang","year":"2021","journal-title":"BMC Anesthesiol"},{"key":"10.1016\/j.jemermed.2025.09.031_bib0024","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0196-0644(05)81219-3","article-title":"Flumazenil: a new benzodiazepine antagonist","volume":"20","author":"Votey","year":"1991","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.jemermed.2025.09.031_bib0025","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1016\/j.ajem.2015.07.031","article-title":"Lack of adverse effects from flumazenil administration: an ED observational study","volume":"33","author":"Nguyen","year":"2015","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.jemermed.2025.09.031_bib0026","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1081\/CLT-120030946","article-title":"Flumazenil\u2014treatment or toxin","volume":"42","author":"Seger","year":"2004","journal-title":"J Toxicol Clin Toxicol"},{"key":"10.1016\/j.jemermed.2025.09.031_bib0027","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1002\/jcph.1614","article-title":"Randomized crossover trial to compare abuse liability of intravenous remimazolam versus intravenous midazolam and placebo in recreational central nervous system depressant users","volume":"60","author":"Schippers","year":"2020","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.jemermed.2025.09.031_bib0028","doi-asserted-by":"crossref","first-page":"209","DOI":"10.2334\/josnusd.21-0051","article-title":"Sedation outcomes for remimazolam, a new benzodiazepine","volume":"63","author":"Oka","year":"2021","journal-title":"J Oral Sci"},{"key":"10.1016\/j.jemermed.2025.09.031_bib0029","first-page":"4594","article-title":"The efficacy and safety of remimazolam tosylate versus propofol in patients undergoing colonoscopy: a multicentered, randomized, positive-controlled, phase iii clinical trial","volume":"12","author":"Chen","year":"2020","journal-title":"Am J Transl Res"},{"key":"10.1016\/j.jemermed.2025.09.031_bib0030","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1101728","article-title":"The use of remimazolam versus propofol for induction and maintenance of general anesthesia: a systematic review and meta-analysis","volume":"14","author":"Ko","year":"2023","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jemermed.2025.09.031_bib0031","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1186\/s40001-023-01440-9","article-title":"Remimazolam tosylate\u2019s long-term sedative properties in ICU patients on mechanical ventilation: effectiveness and safety","volume":"28","author":"Yao","year":"2023","journal-title":"Eur J Med Res"},{"key":"10.1016\/j.jemermed.2025.09.031_bib0032","first-page":"1","article-title":"Remimazolam: the next evolutionary step for sedative-hypnotics","volume":"69","author":"Kramer","year":"2022","journal-title":"Anesth Prog"},{"key":"10.1016\/j.jemermed.2025.09.031_bib0034","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1213\/00000539-199506000-00042","article-title":"The cost of propofol","volume":"80","author":"Johans","year":"1995","journal-title":"Anesth Analg"},{"key":"10.1016\/j.jemermed.2025.09.031_bib0035","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1080\/03007995.2023.2196198","article-title":"Economic benefits of remimazolam compared to midazolam and propofol for procedural sedation in colonoscopies and bronchoscopies","volume":"39","author":"Pedersen","year":"2023","journal-title":"Curr Med Res Opin"},{"issue":"suppl","key":"10.1016\/j.jemermed.2025.09.031_bib0036","doi-asserted-by":"crossref","first-page":"S161","DOI":"10.1016\/j.jval.2024.10.816","article-title":"EE536 The benefit of introducing remimazolam for general anesthesia in Belgian clinical practice","volume":"27","author":"Mihalik","year":"2024","journal-title":"Value Health"}],"container-title":["The Journal of Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0736467925003853?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0736467925003853?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,30]],"date-time":"2025-11-30T03:22:12Z","timestamp":1764472932000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0736467925003853"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":35,"alternative-id":["S0736467925003853"],"URL":"https:\/\/doi.org\/10.1016\/j.jemermed.2025.09.031","relation":{},"ISSN":["0736-4679"],"issn-type":[{"value":"0736-4679","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Remimazolam: A Novel Frontier in Procedural Sedation for Emergency Medicine","name":"articletitle","label":"Article Title"},{"value":"The Journal of Emergency Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jemermed.2025.09.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}